SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,736 | +21.1% | 22,581 | +15.2% | 0.01% | +40.0% |
| Q2 2023 | $2,259 | -10.5% | 19,595 | +7.2% | 0.01% | -16.7% |
| Q1 2023 | $2,525 | +1.1% | 18,276 | -4.8% | 0.01% | -14.3% |
| Q4 2022 | $2,498 | -99.8% | 19,189 | +78.1% | 0.01% | +133.3% |
| Q3 2022 | $1,187,000 | +232.5% | 10,774 | +126.2% | 0.00% | +200.0% |
| Q2 2022 | $357,000 | -5.3% | 4,763 | +4.9% | 0.00% | 0.0% |
| Q1 2022 | $377,000 | -1.3% | 4,541 | +6.6% | 0.00% | 0.0% |
| Q4 2021 | $382,000 | -1.3% | 4,260 | +2.2% | 0.00% | 0.0% |
| Q3 2021 | $387,000 | -69.6% | 4,168 | -74.6% | 0.00% | -66.7% |
| Q2 2021 | $1,275,000 | -68.0% | 16,414 | -69.4% | 0.00% | -70.0% |
| Q1 2021 | $3,979,000 | -52.4% | 53,720 | +9.3% | 0.01% | -37.5% |
| Q4 2020 | $8,354,000 | +54.2% | 49,164 | +27.5% | 0.02% | +33.3% |
| Q3 2020 | $5,417,000 | +22.6% | 38,568 | +39.2% | 0.01% | +20.0% |
| Q2 2020 | $4,420,000 | +131.5% | 27,697 | +42.7% | 0.01% | +100.0% |
| Q1 2020 | $1,909,000 | -20.5% | 19,412 | +3.5% | 0.01% | 0.0% |
| Q4 2019 | $2,401,000 | +87.6% | 18,748 | +122.2% | 0.01% | +66.7% |
| Q2 2019 | $1,280,000 | +25.7% | 8,438 | -1.6% | 0.00% | 0.0% |
| Q1 2019 | $1,018,000 | +29.4% | 8,574 | +14.7% | 0.00% | +50.0% |
| Q4 2018 | $787,000 | -29.9% | 7,476 | +7.6% | 0.00% | -33.3% |
| Q3 2018 | $1,123,000 | +22.3% | 6,948 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $918,000 | +77.9% | 6,948 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $516,000 | +9.1% | 6,948 | -18.5% | 0.00% | 0.0% |
| Q4 2017 | $473,000 | +57.1% | 8,520 | +32.9% | 0.00% | 0.0% |
| Q3 2017 | $301,000 | +81.3% | 6,409 | +29.9% | 0.00% | – |
| Q2 2017 | $166,000 | +13.7% | 4,935 | 0.0% | 0.00% | – |
| Q1 2017 | $146,000 | +7.4% | 4,935 | 0.0% | 0.00% | – |
| Q4 2016 | $136,000 | -77.6% | 4,935 | -50.0% | 0.00% | -100.0% |
| Q3 2016 | $606,000 | +544.7% | 9,870 | +100.0% | 0.00% | – |
| Q2 2016 | $94,000 | -2.1% | 4,935 | 0.0% | 0.00% | – |
| Q1 2016 | $96,000 | -49.7% | 4,935 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $191,000 | +20.1% | 4,935 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $159,000 | +133.8% | 4,935 | +120.8% | 0.00% | – |
| Q2 2015 | $68,000 | +126.7% | 2,235 | 0.0% | 0.00% | – |
| Q1 2015 | $30,000 | -6.2% | 2,235 | 0.0% | 0.00% | – |
| Q4 2014 | $32,000 | -31.9% | 2,235 | 0.0% | 0.00% | – |
| Q3 2014 | $47,000 | -28.8% | 2,235 | 0.0% | 0.00% | – |
| Q2 2014 | $66,000 | +24.5% | 2,235 | 0.0% | 0.00% | – |
| Q1 2014 | $53,000 | +15.2% | 2,235 | 0.0% | 0.00% | – |
| Q4 2013 | $46,000 | – | 2,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |